Drug Trial Radar · NCT07489651
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
Last checked: Nov 19, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
160
Planned (sponsor's estimate)
Start
Apr 20, 2026
Primary completion
Jul 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Reunion Neuroscience IncIndustry
- Sponsor type
- Industry
- First posted
- Mar 24, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 74 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if treatment with a single and/or repeat dose of RE104 for Injection reduces anxiety symptoms in participants with Generalized Anxiety Disorder (GAD) as compared to placebo.
Conditions
- Generalized Anxiety Disorder
Interventions
RE104 for InjectionDrug
Single dose (Part A) or Repeat-dose (Part B), subcutaneous injection(s) of RE104 for Injection
PlaceboDrug
Single-dose (Part A) or Repeat-dose (Part B), subcutaneous injection(s) of 0.9% sodium chloride for injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- RE104 when administered as a single 30 mg dose or as two 30 mg doses 3 weeks apart versus placebo change from Baseline at Week 4 in Hamilton Anxiety Rating Scale (HAM-A) total scoreTime frame: Week 4
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama (UAB) Clinical Research Unit (CRU)
Birmingham, Alabama · Recruiting
Lighthouse Psychiatry
Gilbert, Arizona · Recruiting
Preferred Research Partners, Inc.
Little Rock, Arkansas · Recruiting
Collaborative Neuroscience Research, LLC
Garden Grove, California · Recruiting
Kadima Neuropsychiatry Institute
La Jolla, California · Recruiting
Open Mind Therapeutics
San Francisco, California · Recruiting
TRIP Clinic at Psychedelic Science Institute
Santa Monica, California · Recruiting
Innovative Clinical Research, Inc.
Lauderhill, Florida · Recruiting
University of South Florida
Tampa, Florida · Recruiting
Atlanta Center for Medical Research
Atlanta, Georgia · Recruiting
CenExel iResearch, LLC
Decatur, Georgia · Recruiting
Evergreen Clinical Trials
Norcross, Georgia · Recruiting
CenExel iResearch, LLC
Savannah, Georgia · Recruiting
Uptown Research Institute
Chicago, Illinois · Recruiting
Henry Ford Medical Center - Columbus
Novi, Michigan · Recruiting
Midwest Research Group
Saint Charles, Missouri · Recruiting
UNM Research Program Psychedelic Therapies
Albuquerque, New Mexico · Recruiting
NYU-H+C Clinical and Translational Science Institute
New York, New York · Recruiting
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina · Recruiting
Neuro-Behavioral Clinical Research, Inc.
North Canton, Ohio · Recruiting
Summit Headlands LLC
Portland, Oregon · Recruiting
University of Pennsylvania
Philadelphia, Pennsylvania · Recruiting
Suburban Research Associates
West Chester, Pennsylvania · Withdrawn
Austin Clinical Trial Partners
Austin, Texas · Recruiting
BioBehavioral Research Austion
Austin, Texas · Recruiting
Aim Trials, LLC
Plano, Texas · Recruiting
Cedar Clinical Research
Draper, Utah · Recruiting
Inner Space State Street
Orem, Utah · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.